Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Opicapone for the treatment of Parkinson's disease: real-life data in Spain].
López-Ariztegui N, Mata-Alvarez Santullano M, Tegel I, Almeida F, Sarasa P, Rojo R, Rico-Villademoros F, Abril-Jaramillo J, Bermejo P, Borrue C, Caballol N, Campins-Romeu M, Clavero P, García-Caldentey J, Gómez-Mayordomo V, Labandeira C, Martí-Andrés G, Martínez-Castrillo JC, Martinez-Poles J, Muñoz T, Salom JM, Valderrama-Martín C, Vinagre-Aragón A. López-Ariztegui N, et al. Rev Neurol. 2021 Dec 24;73(s02):S01-S14. doi: 10.33588/rn.73s02.2021461. Rev Neurol. 2021. PMID: 34897643 Free article. Review. Spanish.
[Perioperative management of Parkinson's disease].
Mariscal A, Hernández Medrano I, Alonso Cánovas A, Lobo E, Loinaz C, Vela L, García-Ruiz Espiga P, Martínez Castrillo JC. Mariscal A, et al. Cir Esp. 2011 Aug-Sep;89(7):427-31. doi: 10.1016/j.ciresp.2010.12.012. Epub 2011 Mar 11. Cir Esp. 2011. PMID: 21397216 Spanish.
Dopaminergic agonists in Parkinson's disease.
Alonso Cánovas A, Luquin Piudo R, García Ruiz-Espiga P, Burguera JA, Campos Arillo V, Castro A, Linazasoro G, López Del Val J, Vela L, Martínez Castrillo JC. Alonso Cánovas A, et al. Neurologia. 2014 May;29(4):230-41. doi: 10.1016/j.nrl.2011.04.012. Epub 2011 Jul 2. Neurologia. 2014. PMID: 21724302 Free article. Review. English, Spanish.
[Levodopa in the treatment of Parkinson's disease: myths and realties].
Luquin MR, García-Ruiz PJ, Martí MJ, Rojo A, Vela L, Grandas FJ, Bravo-Utrera M, Burguera JA, Chacón JR, Campos-Arillo VM, Durán-Herrera C, Fernández-García JM, García-Ramos R, Gómez-Esteban JC, Gutierrez J, Juni J, Mata M, Martínez-Castrillo JC, Olivares J, Ribacoba-Montero R, Santos-García D, Sierra M, Valero-Merino C. Luquin MR, et al. Rev Neurol. 2012 Dec 1;55(11):669-88. Rev Neurol. 2012. PMID: 23172094 Free article. Review. Spanish.
Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R. Kulisevsky J, et al. Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Neurologia. 2013. PMID: 23880230 Free article. Review. English, Spanish.
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group. Santos-García D, et al. BMC Neurol. 2016 Feb 25;16:26. doi: 10.1186/s12883-016-0548-9. BMC Neurol. 2016. PMID: 26911448 Free PMC article.
The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
Vela L, Martínez Castrillo JC, García Ruiz P, Gasca-Salas C, Macías Macías Y, Pérez Fernández E, Ybot I, Lopez Valdés E, Kurtis MM, Posada Rodriguez IJ, Mata M, Ruiz Huete C, Eimil M, Borrue C, Del Val J, López-Manzanares L, Rojo Sebastian A, Marasescu R. Vela L, et al. J Neurol Sci. 2016 Sep 15;368:150-4. doi: 10.1016/j.jns.2016.07.003. Epub 2016 Jul 2. J Neurol Sci. 2016. PMID: 27538621
[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].
Garcia-Ruiz PJ, Sanz-Cartagena P, Martinez-Castrillo JC, Ares-Pensado B, Aviles-Olmos I, Blazquez-Estrada M, Fanjul-Arbos S, Garcia-Caldentey J, Gazulla J, Gutierrez-Garcia J, Huete-Anton B, Lucas-Rodenas C, Luquin MR, Martinez-Torres I, Medialdea-Natera P, Mendoza-Rodriguez A, Mir-Rivera P, Posada IJ, Ruiz-Martinez J, Sanchez-Alonso P, Trejo-Gabriel Y Galan JM, Vela L, Pena-Segura JL. Garcia-Ruiz PJ, et al. Rev Neurol. 2018 Mar 1;66(5):163-172. Rev Neurol. 2018. PMID: 29480513 Free article. Review. Spanish.
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.
Santos García D, Jesús S, Aguilar M, Planellas LL, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, López Díaz L, Puente V, García Moreno JM, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues-Boixar O, González Ardura J, Prieto Jurczynska C, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos García D, et al. Eur J Neurol. 2019 Nov;26(11):1399-1407. doi: 10.1111/ene.14008. Epub 2019 Jul 4. Eur J Neurol. 2019. PMID: 31179586
186 results